Filing metadata

Accession number
0000902664-24-000669
Form type
Form 3
Filer
ArriVent BioPharma, Inc.
CIK
CIK 1868279
Filed
Jan 25, 2024
Reporting period
Jan 25, 2024
Description
Initial ownership

Explore SEC Filings Hub